Australia markets close in 4 hours 46 minutes

Soleno Therapeutics Inc (6XC.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
40.66-1.80 (-4.24%)
At close: 07:08PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
34,475
25,189
15,265
21,453
23,191
-
Selling general and administrative
19,099
13,481
9,844
10,806
8,758
-
Total operating expenses
53,574
38,670
25,109
32,259
31,949
-
Operating income or loss
-53,574
-38,670
-25,109
-32,259
-31,949
-
Total other income/expenses net
-2,998
-2,896
742
1,239
7,297
-
Income before tax
-52,030
-38,988
-24,067
-30,910
-24,639
-
Income from continuing operations
-52,030
-38,988
-24,067
-30,910
-24,639
-
Net income
-52,030
-38,988
-24,067
-30,910
-24,639
-
Net income available to common shareholders
-52,030
-38,988
-24,067
-30,910
-24,639
-
Basic EPS
-3.21
-
-2.87
-5.81
-5.85
-13.50
Diluted EPS
-3.21
-
-2.87
-5.81
-5.85
-13.50
Basic average shares
10,195
-
8,397
5,318
4,175
2,276
Diluted average shares
10,195
-
8,397
5,318
4,175
2,276